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The metabolic shift induced in human CD4+ t lymphocytes by stimulation is characterized by an 
upregulation of glycolysis, leading to an augmentation in lactate production. this adaptation has 
already been highlighted with various techniques and reported in several previous studies. We herein 
propose a method to rapidly and noninvasively detect the associated increase in flux from pyruvate to 
lactate catalyzed by lactate dehydrogenase using hyperpolarized 13c magnetic resonance, a technique 
which can be used for in vivo imaging. it was shown that the conversion of hyperpolarized 13c-pyruvate 
to 13C-lactate during the one-minute measurement increased by a mean factor of 3.6 in T cells 
stimulated for 5 days as compared to resting T cells. This method can be extended to other metabolic 
substrates and is therefore a powerful tool to noninvasively analyze t cell metabolism, possibly in vivo.
Upon activation, T lymphocytes rapidly increase their requirements in metabolic substrates to sustain their pro-
liferation and function1. While memory and naive T cells mostly rely on the β-oxidation of fatty acids to produce 
their ATP, it has been shown that the higher need in energy and biosynthetic material required by activated T 
cells leads to an upregulation of the catabolism of glucose2. This metabolic shift towards aerobic glycolysis leads 
to increased lactate production and is equivalent to the phenotype exhibited by cancer cells and first observed in 
1956 by Otto Warburg3. This “Warburgian” behavior has been experimentally revealed in lymphocytes through 
several types of measurements: an increase in the expression of glucose and lactate transporters4–9, an increase 
in glucose uptake demonstrated with radioactive 2-deoxy-D-glucose5,10, an upregulation in enzymes involved in 
glycolysis, including lactate dehydrogenase (LDH)11,12, as well as the measurement of lactate accumulation either 
directly using enzymatic kits5,13, or indirectly by measuring the extracellular acidification rate (ECAR), which 
was shown to be highly correlated with the extracellular lactate production rate14. These metabolic adaptations 
are highlighted by the red arrows in Fig. 1A, which depicts the main steps involved in the regulation of glucose 
metabolism in T cells.
The most direct observation of variations in cellular glycolytic rate can be made through the measurement of 
the flux from glucose to pyruvate and lactate using isotopically labeled precursors. This is done either by deter-
mining the concentrations of 14C-pyruvate and 14C-lactate resulting from the uptake and metabolism of the 
radioactive precursor 14C-glucose15, or by 13C nuclear magnetic resonance (NMR), which provides a direct quan-
tification of the metabolic products of 13C-glucose in intact cells16. The notable advantage of the latter technique is 
that the metabolites can be measured noninvasively and it can therefore be used in vivo, although the lack of sen-
sitivity of 13C NMR severely limits its applications in humans. To partially circumvent this limitation, hyperpo-
larized (HP) 13C magnetic resonance (MR) technologies have been developed to increase the 13C signal intensity 
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by several orders of magnitudes17–19. This enhancement originates from the large 13C nuclear spin polarization of 
the metabolic 13C-precursors, which is obtained using an instrument called a hyperpolarizer20. These precondi-
tioned 13C-molecules are then delivered to cells, tissues, animals or humans, and the kinetics of formation of their 
downstream metabolic products can be measured in real-time using NMR or MR imaging (MRI)21. Although 
it has already been shown that 13C-glucose can be hyperpolarized and injected in rodents to detect glycolysis in 
vivo22,23, the current technology does not easily allow translation of this specific metabolic precursor from pre-
clinical studies to human applications. Instead, 13C-pyruvate, a molecule that is actively taken up by cells using 
monocarboxylate transporters (MCTs) prior to being converted via LDH to 13C-lactate in the cytosol (Fig. 1B), 
has been shown to be an effective alternate HP 13C-probe to highlight the Warburg effect19. HP 13C-pyruvate has 
already been used to scan cancer patients at multiple sites in North America and Europe, and unlike 2-deoxy-2-
(18F)fluoro-D-glucose (18F-FDG) positron emission tomography (PET), HP 13C MR allows glycolytic metabolism 
to be distinguished from oxidative phosphorylation, with the added advantage that it is non-radioactive24,25.
The aim of the present study is to demonstrate through in vitro measurements with human CD4+ T cells that 
HP 13C-pyruvate can detect the metabolic shift induced by the stimulation of T lymphocytes. Ensuring that this 
measurement modality is sufficiently sensitive to reveal the controlled activation of T lymphocytes in cell cultures 
is a necessary step towards in vivo experiments which avoids potentially confounding factors that could arise in 
the metabolically heterogeneous microenvironment of tissues.
Materials and Methods
cell preparation. Healthy donor peripheral blood was obtained according to the declaration of Helsinki 
and upon written informed consent. This study was approved by the ethics committee of the Canton of Vaud, 
Switzerland, and the authors confirm that all experiments were performed in accordance with relevant guidelines 
and regulations. CD4+ T cells were isolated from peripheral mononuclear blood by immunomagnetic selection 
using a CD4 T cell negative depletion kit from Dynal (Dynal Biotech, Invitrogen). CD4+ T cell purity was >95%. 
T cells were isolated, grown and activated at the Ludwig Institute for Cancer research of Lausanne (Switzerland). 
Briefly, T cells were activated by exposure to anti-TCR/CD3 (OKT3, 10 µg/ml) antibodies coated on tissue culture 
plate and soluble anti-CD28 antibody (CD28.2, 1 µg/ml) in RPMI 1640 supplemented with 100 U/ml of IL-2 and 
10% of fetal calf serum (FCS).
protocol for liquid chromatography–mass spectrometry. A set of activated as well as control rest-
ing T cells were incubated in RPMI 1640 supplemented with 100 U/ml of IL-2, 10% of FCS, and 5 mM sodium 
[2,3-13C2]pyruvate for 1 min at 37 °C. They were then snap frozen in liquid nitrogen to halt all metabolic activity. 
Diluted cell media (1:10) was extracted (20 µL) by the addition of cold MeOH:H2O (4:1, 80 µL)26. The extracts 
were centrifuged for 15 min at 14000 rpm at 4 °C and the resulting supernatant was transferred to liquid chro-
matography–mass spectrometry (LC-MS) vials for injection. Cell media extracts were analyzed by Hydrophilic 
Interaction Liquid Chromatography coupled to high resolution mass spectrometry (HILIC - HRMS) in negative 
ionization mode using a 6550 Quadrupole Time-of-Flight (Q-TOF) system interfaced with 1290 UHPLC system 
(Agilent Technologies) as previously described27.
protocol for mRnA sequencing. RNA was extracted and purified from cell lysates prepared from a 
second set of T cells in two different states (resting and activated) using an RNeasy Mini Kit (QIAGEN AG, 
Hombrechtikon, Switzerland). Pair-ended mRNA sequencing was performed on a HiSeq2500 (Illumina, San 
Diego, CA, USA). Purity-filtered reads were adapted and quality trimmed with Cutadapt28. Reads matching to 
ribosomal RNA sequences were removed with FastQ Screen (Babraham Institute, Cambridge, UK). Remaining 
reads were further filtered for low complexity with reaper29. Reads were aligned against Homo sapiens.GRCh38.92 
Figure 1. Main steps involved in the regulation of glucose (A) and pyruvate (B) metabolism in T cells. The red 
arrows highlight the metabolic adaptations.
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genome using STAR30. The number of read counts per gene locus was summarized with htseq-count31 using 
Homo sapiens.GRCh38.92 gene annotation. Quality of the RNA-seq data alignment was assessed using RSeQC32.
Sample preparation for MR measurements. A third set of activated as well as control resting T cells 
were transferred to the MR facility in an incomplete RPMI-1640 medium (modified with sodium bicarbonate, 
without methionine, cystine, or L-glutamine; Sigma-Aldrich, Switzerland) supplemented with 10% FCS in ster-
ile plastic cell culture tubes containing 300 µL of medium. For each experiment, about 5·106 of activated and 
their corresponding control resting T cells were incorporated into two separate 5-mm NMR tubes and unlabeled 
lactate solution was added to each tube to reach a final lactate concentration of 30 mM. The delay between the 
introduction of the cells into the NMR tubes in fresh medium and the completion of the hyperpolarized 13C MR 
measurements was less than 5 min. Cell viability tests indicated a survival rate of over 95% after 5 min in these 
conditions.
custom-designed MR probe. The two NMR tubes containing the activated and resting T cells from a given 
donor were placed in a dual 13C MR probe custom-designed for a 9.4 T/31 cm horizontal bore magnet (Magnex 
Scientific, Abingdon, UK) (Fig. 2). The probe consists of two parallel single-turn saddle 1H radiofrequency (RF) 
coils each enclosing a multi-turn solenoid 13C RF coil designed for 5-mm NMR tubes (Fig. 2A). The two sets of 
coils are separated with an optimal distance (3 cm, center-to-center) that minimizes the inductive coupling while 
maintaining the coils close enough to the magnet isocenter (Fig. 2B). Each one of the two 13C coils is part of a 
resonant circuit, and both circuits are connected to the same coaxial cable through a PIN diode switch (Fig. S1A). 
The two 1H coils are also connected to a single coaxial cable through another PIN diode switch. With this config-
uration, the PIN diode switch allows one to automatically acquire data from the two tubes alternatively with a set 
delay (2 s in the present study) between each acquisition through a preprogrammed switching TTL signal (ON/
OFF) incorporated within the pulse sequence (Fig. S1B).
The probe and NMR tubes were kept at 37 °C ambient temperature during the experiment using the 
MR-compatible fan module of small rodent heater system (SA Instruments, Inc. USA). Both NMR tubes were 
connected by a thin injection line to the output of a remotely-controlled custom-designed injection pump 
through a 2-way flow splitter (Fig. 2C)33,34. Prior to the HP 13C MR experiments, two NMR tubes filled with 
Dulbecco’s phosphate-buffered saline (PBS) 1X solution were inserted inside the RF coils and proton images were 
acquired to position the probe at the magnet isocenter. Static field inhomogeneities were individually corrected 
by manual shimming for each tube and the shim parameters were separately saved for both. The two NMR tubes 
filled with PBS 1X were then replaced by the NMR tubes containing the T cells and the probe was re-inserted into 
the magnet bore at the exact same location.
Hyperpolarization. A volume of 3.5 µL frozen neat [1-13C]pyruvic acid (14.2 M; Sigma-Aldrich) doped 
with 20 mM trityl radical (Albeda, Denmark) was loaded together with 4.7 µL frozen 10 M NaOH solution in 
a custom-built dynamic nuclear polarization (DNP) hyperpolarizer operating at 7 T and 1.00 ± 0.05 K35,36. The 
[1-13C]pyruvic acid sample was polarized for 1.5 h using a 55-mW microwave irradiation set to 196.81 GHz. The 
solid-state 13C polarization build-up was monitored inside the hyperpolarizer by applying a 5° RF pulse every 
5 min. Once polarized to 60 ± 5%, the frozen acid was rapidly dissolved in 6 ml preheated PBS to reach a physio-
logically compatible pH (~pH 7.5). The resulting hyperpolarized solution was automatically transferred into the 
injection pump.
MR acquisition. After 300 μl of HP [1-13C]pyruvate solution was remotely injected within 3 s in each tube 
through the 2-way flow splitter, interleaved 13C MRS measurements were acquired on each sample alternatively 
(5° flip angle rectangular RF pulse with a repetition time of 4 s). The shim parameters optimized for each tube 
were automatically set in between each acquisition. All 13C MR measurements were performed with a Direct 
Drive spectrometer (Agilent, Palo Alto, CA, USA) interfaced to the actively-shielded 9.4 T / 31 cm horizontal 
bore magnet.
Data analysis and statistics. Raw LC-MS files were processed in Profinder B.08.00 software (Agilent 
Technologies) using the targeted data mining in isotopologue extraction mode. The metabolite identification was 
Figure 2. Custom-designed MR probe and injection pump. (A) Sketch of one of the two 1H/13C RF coil pairs 
adapted for 5-mm NMR tubes; (B) Picture of the MR probe highlighting the configuration of the two pairs of 
coils; (C) Top view of the injection pump (1) connected through a 2-way flow splitter (2) to two NMR tubes 
placed inside the MR probe (3).
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based on accurate mass and retention time matching against an in-house database containing data on 600 polar 
metabolite standards (analyzed in the same analytical conditions). The Extracted Ion Chromatogram areas (EICs) 
of each isotopologue (M + , M + 1, M + 2 and M + 3) were corrected for natural isotope abundance37 and the label 
incorporation or 13C enrichment of lactate was calculated based on relative isotopologue abundance (in %), in 
each one of two analyzed conditions38.
The MR signal integrals were quantified from summed spectra using the peak fitting module from the 
OriginPro 2019 (OriginLab, USA) Peak Analyzer toolbox. The signal integral ratios between metabolic product 
([1-13C]lactate) and substrate ([1-13C]pyruvate) were compared across all experiments with resting and activated 
T cells. The overlapping resonance from the impurity identified at 183 ppm was subtracted from the lactate peak 
using a protocol illustrated in Fig. S2.
Statistical analyses were performed on the data represented on a logarithmic scale. This was motivated by the 
fact that the variance of the lactate-to-pyruvate ratio increases with the mean, which is a typical characteristic 
of strictly positive data. From a biological point of view, we can also expect all resting T cells to exhibit a sim-
ilar metabolic activity, whereas the stimulation may alter the T cells of each donor in a less homogenous man-
ner. The paired (resting and activated condition for each donor) lactate-to-pyruvate ratios were analyzed using 
random-intercept linear mixed models with state (resting/activated) as fixed effect and patients as random effects. 
Linear mixed models have the Student’s paired T-test as special case (same estimates and inference) but comes 
with the following advantages: the model assessment can be performed on n = 8 (independent conditionally to 
the fixed and random effects) residuals instead of 4, and that the dependence between the paired observations can 
be quantified. The same statistical model was used to analyze the mRNA sequencing and LC-MS data.
Results and Discussion
It has previously been shown that the mRNA expression of MCT1 and LDHA is strongly elevated in activated 
human T lymphocytes and that lactate concentration increases in the extracellular environment39. To verify that 
the cells used in the present study exhibited a similar behavior, mRNA sequencing and LC-MS analysis after 
incubation in a medium supplemented with [2,3-13C2]pyruvate were performed on sets of T cell cultures in two 
different states (resting and activated). Given that about 3% of the endogenous lactate bears one 13C atom while 
only 0.03% has two, doubly 13C-labeled pyruvate was used to ensure that its conversion to lactate could be meas-
ured by LC-MS with high sensitivity and accuracy.
The mRNA analysis demonstrated that LDHA expression significantly increased upon activation (p = 0.032), 
while none of the MCTs were significantly more expressed in the activated state (Fig. 3A–E). This result is in good 
agreement with a previous study showing that LDHA stays highly overexpressed even after 6 days of stimulation 
while MCTs expression reduces from an early high expression within the first hours of stimulation to return to 
their resting level after such a long activation period39.
The statistical analysis of the LC-MS measurements shows a highly significant increase (p = 0.004) of the [2,3-
13C2]lactate-to-[2,3-13C2]pyruvate ratio upon activation, with a 95% confidence interval of [4.54, 28.76] (Fig. 3F). 
For the 4 donors, the measured ratio was larger in activated T cells than in resting T cells. The mean enhancement 
factor was 11.4 and the paired observations were highly correlated (ρ = 0.74).
The higher LDHA expression together with the observed increase in [2,3-13C2]lactate-to-[2,3-13C2]pyruvate 
ratio can be associated with the upregulation of glycolysis triggered by the stimulation. Note that the residuals 
analysis of the linear mixed models for all the above-described measurements shows a good model fit (homosce-
dasticity and symmetry around 0; Fig. S3).
In the MR measurements performed on another set of T cell cultures in two different states (resting and acti-
vated), the formation of [1-13C]lactate was readily detected following the injection of hyperpolarized [1-13C]pyru-
vate in both resting and in vitro activated T cells (Fig. 4). Although the observed lactate signal is the sum of both 
intra- and extracellular lactate, the line width of the resonance being too large to differentiate the two pools40, 
most of the detected signal likely originated from extracellular lactate. The [1-13C]pyruvate hydrate resonance 
was also detected. However, despite the relatively high SNR of the [1-13C]pyruvate resonance, no 13C-bicarbonate 
signal could be observed, which demonstrates that the flux through pyruvate dehydrogenase (PDH) was low and 
that only a minute fraction of the injected pyruvate was used to feed the tricarboxylic acid (TCA) cycle. In all 4 
MR experiments, it was observed that the lactate-to-pyruvate signal ratio was larger in activated T cells than in 
resting T cells (Fig. 5A). This increase in 13C labeling of the lactate pool can be explained by an increased flux 
through LDH since the mRNA analysis showed that LDHA expression is upregulated in the activated state. It 
also correlates with the LC-MS data which demonstrated that, within a 1 min time window, the lactate labeled 
from pyruvate is significantly larger in the activated state. The statistical analysis of the MR data showed that the 
lactate-to-pyruvate signal ratio significantly increased (p = 0.009) with a mean enhancement factor of 3.6, with 
a 95% confidence interval of [1.85,7.15] and that the paired observations were highly correlated (ρ = 0.84). The 
residuals analysis of the linear mixed models fit of the lactate-to-pyruvate signal ratio on the logarithmic scale 
is presented in Fig. 5B, and as in the case of the mRNA sequencing and LC-MS data analysis, it exhibits a good 
model fit.
Thanks to the dual 13C MR probe used in this study, measurements in both activated and resting T cells from 
each donor could be done simultaneously, thereby ensuring that the two cell suspensions had been exposed 
to the same environmental conditions after having been transported to the MR facility. This is crucial since T 
lymphocytes are known to be sensitive cells that struggle to survive ex vivo for long periods of time, especially 
in depleted medium41. It can also be seen from Fig. 4 that the noise level in the sets of 13C spectra acquired from 
both sides of the dual probe is equivalent, which demonstrates that the sensitivity was identical in each pair of 
measurements done in parallel. Moreover, the mean [1-13C]pyruvate SNR of the first spectrum was very similar 
in all 8 measurements (2500 ± 350).
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HP 13C MR is a well-adapted technique to study T cell metabolism since in optimized conditions the number 
of cells needed for a measurement in a standard NMR tube only need to be on the order of 106, as in the present 
study, whereas previous 13C NMR studies required more than 109 cells trapped inside agarose beads16. In addition, 
because long acquisition times are required to be able to observe the increased lactate production in activated T 
cell preparations using non-HP 13C MR (on the order of 30 min in ref. 16), it is necessary to carefully control the 
oxygen influx and possibly perfuse the cells to ensure that their state does not change during the acquisitions. By 
contrast, because the measurements only last for a few minutes, this is not necessary for HP 13C MR experiments.
The mean lactate-to-pyruvate ratio deduced from the HP 13C MR experiments is about 3 times smaller than 
the mean ratio deduced from the LC-MS measurements. This difference is most likely due to a convolution of 
several of the following factors: first and foremost, these two types of measurements were not performed on the 
same set of cells, and, as evident from the observed heterogeneity in the data, the ratio can dramatically vary 
across donors. Second, as previously highlighted by Witney et al.42, the measured conversion rate depends on 
both pyruvate and lactate extracellular concentrations and the exact initial concentrations may have slightly var-
ied across experiments. Third, although the 13C MR data was integrated over a 1 min time window, the mixing 
within the NMR tubes was most likely not instantaneous following the injection of the HP 13C-pyruvate solution 
and the initial uptake and conversion rate was probably significantly slower than in the cells measured by LC-MS.
The choice of incubation time (5 days) was motivated by the fact that previous studies had shown that CD4+ 
T cells maintain an increased glycolytic activity during prolonged stimulation39,43. This does not mean that the 
lactate-to-pyruvate signal that can be observed using HP 13C-pyruvate is maximum after this particular activa-
tion period since, as shown in Fig. 1B, the lactate signal intensity will depend on the activities of both MCTs and 
LDH, and the expression of both these enzymes vary during this stimulation period. In fact, the data published 
by Renner et al. suggests that a 48 h stimulation period might lead to a higher lactate-to-pyruvate signal since the 
mRNA expression of both LDHA and MCT1 are higher after 48 h than after 6 day of stimulation39.
Since our experiments were not performed with glucose as substrate, it is not straightforward to compare 
our results with the data obtained in previous metabolic studies with T lymphocytes. Nevertheless, the four-fold 
increase in lactate production upon activation is in good agreement with numbers previously reported in studies 
performed with glucose, where a 3-7 fold increase was observed39,44,45. A more quantitative comparison between 
the techniques should be possible using HP 13C-glucose. The main conclusion of our study is that the metabolic 
adaptation triggered by T cell stimulation can be readily detected by HP 13C MR at much higher sensitivity than 
reported to date. The proposed method can complement the standard ECAR measurements with the advantage 
Figure 3. MCT1 (A), MCT2 (B), MCT4 (C), LDHA (D), and LDHB (E) expression measured by mRNA 
sequencing on human T lymphocytes in both resting and activated states obtained from 4 donors. Each color 
corresponds to a different donor. Only the expression of LDHA was significantly different between the two states; 
(F) [2,3-13C2]lactate-to-[2,3-13C2]pyruvate ratio deduced from LC-MS experiments performed on human T 
lymphocytes from 4 other donors following the incubation of the cells in a medium containing 5 mM sodium [2,3-
13C2]pyruvate for 1 min at 37 °C. The ratio significantly increases when comparing the activated to the resting state.
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that metabolic fluxes are directly measured and that there is no need to add enzyme inhibitors. As illustrated in 
the present study, LC-MS can also be used to provide complementary measurements of metabolic fluxes using 
isotopically labeled substrates. However, the non-destructive nature of HP 13C MR makes it a unique tool for 
longitudinal in vitro studies.
Figure 4. Representative time evolution of the 13C MR spectrum detected after the injection of HP [1-13C]
pyruvate solution in resting (A) and activated (B) T cells. The delay between each acquisition was set to 4 s, 
starting 2 s after the beginning of the injection. The sum of the 1st to 15th spectra is displayed on the top. Along 
with the substrate resonance at 171.1 ppm, two products were detected: [1-13C]pyruvate hydrate at 179.5 ppm 
and [1-13C]lactate at 183.2 ppm. The impurity signal (marked with a star) overlapping with the lactate peak was 
subtracted from the spectra prior to quantification of the lactate signal.
Figure 5. (A) Lactate-to-pyruvate ratio deduced from the hyperpolarized 13C MRS experiments performed 
on human T lymphocytes in two different states (resting and activated) obtained from 4 donors. Each color 
corresponds to a different donor. The lactate-to-pyruvate ratio significantly increases when comparing the 
activated to the resting state; (B) Residual analysis of the random-intercept linear mixed models fits of lactate-
to-pyruvate ratio. The plot shows the residuals (y-axis) versus the fitted values (x-axis). Point colors correspond 
to donor and symbols to states: dots for resting and triangles for activated. These model checks, showing 
symmetry of the residuals around 0 and homoscedasticity, suggest a good fit of the model to the data.
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Our dual parallel measurements (activated vs. resting T cells) could be extended to a larger number of parallel 
measurements using an integrated microfluidic system46, for instance to compare T cells that have been stimu-
lated for a number of different time periods in a single measurement. HP 13C MR can also be used to directly and 
noninvasively analyze the behavior of T cells in presence of antigens, possibly in vivo. Since it is well known that 
cancer cells will also compete for pyruvate21, HP [1-13C]pyruvate might however not be the ideal substrate to 
detect T cell activation in the tumor microenvironment and alternative HP 13C tracers shall be tested. We there-
fore plan on extending the proposed method to other metabolic substrates such as fatty acid and glutamine, the 
uptake and metabolism of which is also known to be altered in T lymphocytes upon activation11.
Data availability
All data is available from the authors upon reasonable request.
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